EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudiePragmatische StudieOpen Access · CC BY-NC-ND 4.0

Renal Function and Natriuresis-Guided Diuretic Therapy – A Pre-Specified Analysis from the PUSH-AHF Trial

Kevin Damman iD, Iris E Beldhuis iD, Peter van der Meer, Jan A Krikken, Jenifer E Coster, Wybe Nieuwland, Dirk J van Veldhuisen iD, Adriaan A Voors iD, Jozine M Ter Maaten iD

European Journal of Heart Failure · 2024

DOI: 10.1002/ejhf.3228 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Heart Failure, 2024. Verfasst von Kevin Damman und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Groningen, Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Glomerular Filtration Rate, Heart Failure, Natriuresis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hartstichting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

In a randomized controlled trial, we recently showed that a natriuresis-guided diuretic approach improved natriuresis and diuresis in patients with acute heart failure (HF). In this pre-specified analysis, we investigated the association between (worsening) renal function, outcomes and the effect of intensive natriuresis-guided loop diuretic therapy as compared with standard of care. Methods and results The Pragmatic Urinary Sodium-based algoritHm in Acute Heart Failure (PUSH-AHF) trial randomized patients to natriuresis-guided diuretic therapy or standard of care. Serum creatinine and estimated glomerular filtration rate (eGFR) were assessed at fixed timepoints, and worsening renal function (WRF) was assessed at 72 h. The primary outcome was the interaction between randomized treatment allocation, baseline eGFR and the dual primary outcome of PUSH-AHF: total natriuresis at 24 h and time to all-cause mortality or HF rehospitalization at 180 days. In 309 patients, median baseline eGFR was 53 (35–73) ml/min/1.73 m2, and 58% had eGFR <60 ml/min/1.73 m2. Baseline eGFR did not significantly modify the treatment effect of natriuresis-guided diuretic therapy on natriuresis at 24 h (p for interaction = 0.730). However, baseline eGFR significantly modified the effect on all-cause mortality and HF rehospitalization (p for interaction = 0.017): the risk of this second primary outcome was lower in patients with lower eGFR who were randomized to the natriuresis-guided group. In the natriuresis-guided arm, eGFR decreased more (−11.0 vs. −6.91 ml/min/1.73 m2; p = 0.002) during the first 3 days, but this effect was attenuated at discharge (−10.3 vs. −8.69 ml/min/1.73 m2; p = 0.38). WRF was more frequently observed in patients randomized to natriuresis-guided treatment, but was not associated with worse clinical outcomes.

Conclusions

Natriuresis-guided diuretic treatment improved diuresis and natriuresis irrespective of baseline eGFR and occurrence of WRF, was effective even in patients with low eGFR, and the observed effect on eGFR was transient and not associated with worse clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerular Filtration RateHeart FailureNatriuresisHumansFemaleMaleAgedMiddle AgedDiureticsSodium Potassium Chloride Symporter InhibitorsTreatment OutcomeAcute DiseaseCreatinine

Stichwörter der Autor:innen

Acute heart failureNatriuresisWorsening renal function

Substanzen

DiureticsSodium Potassium Chloride Symporter InhibitorsCreatinine

Autor:innen und Institutionen

  • University of Groningen, Department of Cardiology, University Medical Centre Groningen, Groningen, The Netherlands.

ORCID-Profile: Kevin Damman, Iris E Beldhuis, Dirk J van Veldhuisen, Adriaan A Voors, Jozine M Ter Maaten

Förderung

  • Hartstichting

Zitieren

APA

Damman, K., Beldhuis, I. E., van der Meer, P., Krikken, J. A., Coster, J. E., Nieuwland, W., van Veldhuisen, D. J., Voors, A. A., & Ter Maaten, J. M. (2024). Renal Function and Natriuresis-Guided Diuretic Therapy – A Pre-Specified Analysis from the PUSH-AHF Trial. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3228

Vancouver

Damman K, Beldhuis IE, van der Meer P, Krikken JA, Coster JE, Nieuwland W, et al. Renal Function and Natriuresis-Guided Diuretic Therapy – A Pre-Specified Analysis from the PUSH-AHF Trial. European Journal of Heart Failure. 2024. doi:10.1002/ejhf.3228

BibTeX
@article{Damman2024,
  author = {Damman, Kevin and Beldhuis, Iris E and van der Meer, Peter and Krikken, Jan A and Coster, Jenifer E and Nieuwland, Wybe and van Veldhuisen, Dirk J and Voors, Adriaan A and Ter Maaten, Jozine M},
  title = {Renal Function and Natriuresis-Guided Diuretic Therapy – A Pre-Specified Analysis from the PUSH-AHF Trial},
  journal = {European Journal of Heart Failure},
  year = {2024},
  doi = {10.1002/ejhf.3228}
}
Kostenlos starten →